Pinteon Therapeutics
Newton Centre, US · Founded 2014 · Delaware corporation
Founders & leadership
JR
Jason R. DingesExecutive
JL
Jeffrey L. IvesNamed on SEC filing
Board
WN
Westley NolinBoard director
Reported raises · per SEC filings
Form D private placements$39.2M disclosed across 2 rounds · 2014–2022
▶$29.2MraisedNov 2025 · 2 investors · BiotechnologyRule 506(b)
▶$29.2MraisedNov 2025 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Westley NolinDirector
- Jason R. DingesExecutive Officer, Director
- Offering amount
- $32.1M
- Amount sold
- $29.2M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedAug 2017 · 1 investors · Other TechnologyRule 506(b)
▶$10MraisedAug 2017 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey L. IvesDirector
- Westley B. NolinDirector
- Jason R. DingesDirector
- Offering amount
- $17.5M
- Amount sold
- $10M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Pinteon Therapeutics raised?
- Pinteon Therapeutics has disclosed $39.2M raised across 2 rounds.
- Where is Pinteon Therapeutics headquartered?
- Pinteon Therapeutics is headquartered in Newton Centre, US.